Inventor
MUELLER REINHOLD
DE27 patents
⚠️ This page may combine multiple inventors who share the name “MUELLER REINHOLD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT GMBH & CO KG
6 patentsUS6696437B1Feb 24, 2004
Heterocyclically substituted benzimidazoles, the production and application thereof
ABBOTT GMBH & CO KG92 citations97
USRE39608EMay 1, 2007
Substituted benzimidazoles and their use as PARP inhibitors
ABBOTT GMBH & CO KG30 citations92
US7041675B2May 9, 2006
Heterocyclic compounds and their use as PARP inhibitors
ABBOTT GMBH & CO KG22 citations92
US6737421B1May 18, 2004
Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors
ABBOTT GMBH & CO KG37 citations90
US7491729B2Feb 17, 2009
3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof
ABBOTT GMBH & CO KG9 citations83
US7026311B2Apr 11, 2006
Dibenzodiazepine derivatives, their preparation and use
ABBOTT GMBH & CO KG0 citations42
ABBVIE DEUTSCHLAND
4 patentsUS10464976B2Nov 5, 2019
Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
ABBVIE DEUTSCHLAND2 citations71
US10040852B2Aug 7, 2018
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
ABBVIE DEUTSCHLAND0 citations51
US9255146B2Feb 9, 2016
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
ABBVIE DEUTSCHLAND0 citations51
US9394363B2Jul 19, 2016
Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
ABBVIE DEUTSCHLAND1 citations50
SEQUENOM INC
3 patentsUS9605313B2Mar 28, 2017
Methods and processes for non-invasive assessment of genetic variations
SEQUENOM INC6 citations84
US11312997B2Apr 26, 2022
Methods and processes for non-invasive assessment of genetic variations
SEQUENOM INC2 citations73
US10738359B2Aug 11, 2020
Methods and processes for non-invasive assessment of genetic variations
SEQUENOM INC4 citations73